Abstract: A display device having a display panel including first and second folding areas, a first non-folding area between the first and second folding areas, and a second non-folding area. A panel support is disposed on a lower side of the display panel and includes a first lattice pattern overlapping the first folding area, a second lattice pattern overlapping the second folding area, a first flat plate overlapping the first non-folding area, and a second flat plate overlapping the second non-folding area. An adhesive member is interposed between the display panel and the panel support and includes a first adhesive member disposed directly on the first flat plate and a second adhesive member disposed directly on the second flat plate. An adhesive force between the first adhesive member and the first flat plate is greater than an adhesive force between the second adhesive member and the second flat plate.

Abstract: A display device includes: a display panel; a driver IC positioned on the display panel; a supporting member positioned under the display panel; and a lower adhesive layer positioned between the display panel and the supporting member. A storage modulus of the lower adhesive layer is about 0.020 MPa to about 0.030 MPa at about 1 Hz and about 140° C.

Abstract: A peptide with anti-inflammatory activity is described, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. An inflammatory composition comprising the above mentioned peptides is also described. The peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising those peptides can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a method of treating autoimmune disease comprising administering to a subject in need thereof a composition comprising an isolated peptide of SEQ ID NO: 1.

Abstract: The present invention relates to a method of treating bone, joint, muscle, and connective tissue related inflammatory disease comprising administering to a subject in need thereof a composition comprising an isolated peptide of SEQ ID NO: 1.

Abstract: The present invention relates to a conjugate of cell penetrating peptide and an active ingredient; and its use. Specifically, a conjugate including a cell penetrating peptide which is a peptide comprising any one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 178, a fragment of any one sequence of SEQ ID NO: 2 to SEQ ID NO: 178, or a peptide having above 80% homology with the above-mentioned sequence; and a composition comprising the same are disclosed.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has an outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a conjugate of cell penetrating peptide and an active ingredient; and its use. Specifically, a conjugate including a cell penetrating peptide which is a peptide comprising any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 156, a fragment of any one sequence of SEQ ID NO: 1 to SEQ ID NO: 156, or a peptide having above 80% homology with the above-mentioned sequence; and a composition comprising the same are disclosed.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A display device includes a display panel and a housing structure foldable together with each other, each including a first unfolded portion, a first folded portion, a second unfolded portion, a second folded portion and a third unfolded portion in order along a first direction, and first and second end portions respectively corresponding to outer edges of the third and second unfolded portions. The second end portion of the housing structure further includes a body portion, edge portions extended from the body portion and facing each other along a second direction, and a first protruding portion between the edge portions and protruded further from the edge portions in a direction away from the body portion. The display panel which is folded disposes the first protruding portion of the second end portion facing the display panel at the second unfolded portion thereof.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a conjugate of cell penetrating peptide and an active ingredient; and its use. Specifically, a conjugate including a cell penetrating peptide which is a peptide comprising any one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 178, a fragment of any one sequence of SEQ ID NO: 2 to SEQ ID NO: 178, or a peptide having above 80% homology with the above-mentioned sequence; and a composition comprising the same are disclosed.

Abstract: A foldable display device includes: a display panel; a window disposed on the display panel; and a functional member having an elastic modulus and being disposed between the display panel and the window or at least partially on the window, the functional member including a plurality of first discontinuities having a greater elastic modulus than the elastic modulus of the first functional member.

Abstract: The present invention relates to a conjugate of cell penetrating peptide and an active ingredient; and its use. Specifically, a conjugate including a cell penetrating peptide which is a peptide comprising any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 156, a fragment of any one sequence of SEQ ID NO: 1 to SEQ ID NO: 156, or a peptide having above 80% homology with the above-mentioned sequence; and a composition comprising the same are disclosed.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, the peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A display device includes a display panel and a housing structure foldable together with each other, each including a first unfolded portion, a first folded portion, a second unfolded portion, a second folded portion and a third unfolded portion in order along a first direction, and first and second end portions respectively corresponding to outer edges of the third and second unfolded portions. The second end portion of the housing structure further includes a body portion, edge portions extended from the body portion and facing each other along a second direction, and a first protruding portion between the edge portions and protruded further from the edge portions in a direction away from the body portion. The display panel which is folded disposes the first protruding portion of the second end portion facing the display panel at the second unfolded portion thereof.

Abstract: A foldable display device may include a display panel, a window disposed on a first surface of the display panel, a metal plate disposed on a second surface of the display panel opposite to the first surface, and a functional member disposed between the display panel and the metal plate, the functional member including a first functional layer in which a plurality of holes are formed and a filler filling each of the holes. An elastic modulus of the filler may be greater than an elastic modulus of the first functional layer.

Abstract: A display device having a display panel including first and second folding areas, a first non-folding area between the first and second folding areas, and a second non-folding area. A panel support is disposed on a lower side of the display panel and includes a first lattice pattern overlapping the first folding area, a second lattice pattern overlapping the second folding area, a first flat plate overlapping the first non-folding area, and a second flat plate overlapping the second non-folding area. An adhesive member is interposed between the display panel and the panel support and includes a first adhesive member disposed directly on the first flat plate and a second adhesive member disposed directly on the second flat plate. An adhesive force between the first adhesive member and the first flat plate is greater than an adhesive force between the second adhesive member and the second flat plate.